[Experimental evaluation of the effect of glycine and its phosphorylated derivative on ischemic brain injury].
The effect of glycine and its phosphorylated derivative (AKF 90-7) on the ischemic brain injury in experimental animals has been studied. The therapeutic injection of glycine and AKF 90-7 (50 100 mg/kg) increased the survival of laboratory animals under the conditions of ischemia caused by ligation of the carotid artery. In a dose of 50 mg/kg, AKF 90-7 was more effective than glycine in activating enzymes of the antioxidant system and preventing the formation of lipid peroxidation products.